Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007, Article ID 65704, 5 pages
http://dx.doi.org/10.1155/2007/65704
Clinical Study

Plasma Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Obsessive Compulsive Disorder

1Department of Psychiatry, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, Turkey
2Department of Immunology, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, Turkey
3Department of Pathology, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak 67600, Turkey

Received 7 December 2006; Revised 29 December 2006; Accepted 30 December 2006

Copyright © 2007 N. Konuk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Connor and B. E. Leonard, “Depression, stress and immunological activation: the role of cytokines in depressive disorders,” Life Sciences, vol. 62, no. 7, pp. 583–606, 1998. View at Publisher · View at Google Scholar
  2. B. E. Leonard, “Changes in the immune system in depression and dementia: causal or co-incidental effects?,” International Journal of Developmental Neuroscience, vol. 19, no. 3, pp. 305–312, 2001. View at Publisher · View at Google Scholar
  3. D. Hinze-Selch and T. Pollmächer, “In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research,” Brain, Behavior, and Immunity, vol. 15, no. 4, pp. 282–318, 2001. View at Publisher · View at Google Scholar · View at PubMed
  4. M. Maes, A.-H. Lin, L. Delmeire et al., “Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events,” Biological Psychiatry, vol. 45, no. 7, pp. 833–839, 1999. View at Publisher · View at Google Scholar
  5. F. Brambilla, L. Bellodi, and G. Perna, “Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy,” Psychiatry Research, vol. 89, no. 1, pp. 21–27, 1999. View at Publisher · View at Google Scholar
  6. M. H. Rapaport and M. B. Stein, “Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia,” Anxiety, vol. 1, no. 2, pp. 50–53, 1994. View at Google Scholar
  7. M. Maes, H. Y. Meltzer, and E. Bosmans, “Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1β and IL-6 concentrations,” Neuropsychobiology, vol. 30, no. 2-3, pp. 57–60, 1994. View at Google Scholar
  8. R. Weizman, N. Laor, Y. Barber et al., “Cytokine production in obsessive-compulsive disorder,” Biological Psychiatry, vol. 40, no. 9, pp. 908–912, 1996. View at Publisher · View at Google Scholar
  9. F. Brambilla, G. Perna, L. Bellodi et al., “Plasma interleukin-1β and tumor necrosis factor concentrations in obsessive-compulsive disorders,” Biological Psychiatry, vol. 42, no. 11, pp. 976–981, 1997. View at Publisher · View at Google Scholar
  10. D. Denys, S. Fluitman, A. Kavelaars, C. Heijnen, and H. Westenberg, “Decreased TNF-α and NK activity in obsessive-compulsive disorder,” Psychoneuroendocrinology, vol. 29, no. 7, pp. 945–952, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. P. Monteleone, F. Catapano, M. Fabrazzo, A. Tortorella, and M. Maj, “Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder,” Neuropsychobiology, vol. 37, no. 4, pp. 182–185, 1998. View at Publisher · View at Google Scholar
  12. A. V. Ravindran, J. Griffiths, Z. Merali, and H. Anisman, “Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls,” Journal of Affective Disorders, vol. 52, no. 1–3, pp. 1–10, 1999. View at Publisher · View at Google Scholar
  13. S. E. Swedo, H. L. Leonard, B. B. Mittleman et al., “Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever,” American Journal of Psychiatry, vol. 154, no. 1, pp. 110–112, 1997. View at Google Scholar
  14. P. Vassalli, “The pathophysiology of tumor necrosis factors,” Annual Review of Immunology, vol. 10, pp. 411–452, 1992. View at Publisher · View at Google Scholar · View at PubMed
  15. S. J. Hopkins and N. J. Rothwell, “Cytokines and the nervous system I: expression and recognition,” Trends in Neurosciences, vol. 18, no. 2, pp. 83–88, 1995. View at Publisher · View at Google Scholar
  16. N. J. Rothwell and S. J. Hopkins, “Cytokines and the nervous system II: actions and mechanisms of action,” Trends in Neurosciences, vol. 18, no. 3, pp. 130–136, 1995. View at Publisher · View at Google Scholar
  17. M. Fiore, E. Alleva, L. Probert, G. Kollias, F. Angelucci, and L. Aloe, “Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-α,” Physiology and Behavior, vol. 63, no. 4, pp. 571–576, 1998. View at Publisher · View at Google Scholar
  18. S. F. Maier and L. R. Watkins, “Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition,” Psychological Review, vol. 105, no. 1, pp. 83–107, 1998. View at Publisher · View at Google Scholar
  19. T. Kishimoto, “Interleukin-6 and its receptor in autoimmunity,” Journal of Autoimmunity, vol. 5, pp. 123–132, 1992. View at Publisher · View at Google Scholar
  20. B. Schobitz, E. R. de Kloet, W. Sutanto, and F. Holsboer, “Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain,” European Journal of Neuroscience, vol. 5, no. 11, pp. 1426–1435, 1993. View at Publisher · View at Google Scholar
  21. B. Schöbitz, E. R. de Kloet, and F. Holsboer, “Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain,” Progress in Neurobiology, vol. 44, no. 4, pp. 397–432, 1994. View at Publisher · View at Google Scholar
  22. M. B. First, R. L. Spitzer, M. Gibbon, and J. B. W. Williams, Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV), American Psychiatric Press, Washington, DC, USA, 1997.
  23. A. Özkürkçügil, Ö. Aydemir, M. K. Yıldız, A. Esen Danacı, and E. Köroğlü, “DSM IV Eksen I bozuklukları için yapılandırılmış klinik görüşmenin Türkçe'ye uyarlanması ve güvenilirlik çalışması,” İlaç ve Tedavi Dergisi, vol. 12, no. 4, pp. 233–236, 1999. View at Google Scholar
  24. W. K. Goodman, L. H. Price, S. A. Rasmussen et al., “The Yale-Brown obsessive compulsive scale. II. Validity,” Archives of General Psychiatry, vol. 46, no. 11, pp. 1012–1016, 1989. View at Google Scholar
  25. M. Hamilton, “A rating scale for depression,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 23, no. 1, pp. 56–62, 1960. View at Google Scholar
  26. M. Hamilton, “The assessment of anxiety states by rating,” The British Journal of Medical Psychology, vol. 32, no. 1, pp. 50–55, 1959. View at Google Scholar
  27. A. Akdemir, M. H. Türkçapar, S. D. Örsel, N. Demirergi, I. Dag, and M. H. Özbay, “Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale,” Comprehensive Psychiatry, vol. 42, no. 2, pp. 161–165, 2001. View at Publisher · View at Google Scholar · View at PubMed
  28. M. K. Yazıcı, B. Demir, N. Tanrıverdi, E. Karaağaoğlu, and P. Yolaç, “Hamilton Anksiyete Değerlendirme Ölçeği, değerlendiriciler arası güvenirlik ve geçerlik çalışması,” Türk Psikiyatri Dergisi, vol. 9, no. 2, pp. 114–120, 1998. View at Google Scholar
  29. B. B. Mittleman, F. X. Castellanos, L. K. Jacobsen, J. L. Rapoport, S. E. Swedo, and G. M. Shearer, “Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease,” Journal of Immunology, vol. 159, no. 6, pp. 2994–2999, 1997. View at Google Scholar
  30. J. Zohar, J. L. Kennedy, E. Hollander, and L. M. Koran, “Serotonin-1D hypothesis of obsessive-compulsive disorder: an update,” The Journal of Clinical Psychiatry, vol. 65, pp. 18–21, 2004. View at Google Scholar
  31. R. Mössner, A. Heils, G. Stöber, O. Okladnova, S. Daniel, and K.-P. Lesch, “Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6,” Neurochemistry International, vol. 33, no. 3, pp. 251–254, 1998. View at Publisher · View at Google Scholar
  32. K. Brebner, S. Hayley, R. Zacharko, Z. Merali, and H. Anisman, “Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α: central monoamine, corticosterone, and behavioral variations,” Neuropsychopharmacology, vol. 22, no. 6, pp. 566–580, 2000. View at Publisher · View at Google Scholar
  33. L. L. Carpenter, G. R. Heninger, C. J. McDougle, A. R. Tyrka, C. N. Epperson, and L. H. Price, “Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania,” Psychiatry Research, vol. 112, no. 3, pp. 257–262, 2002. View at Publisher · View at Google Scholar
  34. Z. Kronfol and D. G. Remick, “Cytokines and the brain: implications for clinical psychiatry,” American Journal of Psychiatry, vol. 157, no. 5, pp. 683–694, 2000. View at Publisher · View at Google Scholar
  35. S. Lanquillon, J.-C. Krieg, U. Bening-Abu-Shach, and H. Vedder, “Cytokine production and treatment response in major depressive disorder,” Neuropsychopharmacology, vol. 22, no. 4, pp. 370–379, 2000. View at Publisher · View at Google Scholar
  36. S. Theodoropoulou, G. Spanakos, C. N. Baxevanis et al., “Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients,” Schizophrenia Research, vol. 47, no. 1, pp. 13–25, 2001. View at Publisher · View at Google Scholar
  37. R. Ganguli, J. S. Brar, K. N. R. Chengappa, Z. W. Yang, V. L. Nimgaonkar, and B. S. Rabin, “Autoimmunity in schizophrenia: a review of recent findings,” Annals of Medicine, vol. 25, no. 5, pp. 489–496, 1993. View at Google Scholar
  38. R. Tükel, E. Ertekin, S. Batmaz et al., “Influence of age of onset on clinical features in obsessive-compulsive disorder,” Depression and Anxiety, vol. 21, no. 3, pp. 112–117, 2005. View at Publisher · View at Google Scholar · View at PubMed
  39. F. Zavala, “Benzodiazepines, anxiety and immunity,” Pharmacology and Therapeutics, vol. 75, no. 3, pp. 199–216, 1997. View at Publisher · View at Google Scholar
  40. M. Maes, “The immunoregulatory effects of antidepressants,” Human Psychopharmacology, vol. 16, no. 1, pp. 95–103, 2001. View at Publisher · View at Google Scholar · View at PubMed
  41. M. Bilici, Y. Tekelioğlu, S. Efendioğlu, E. Ovali, and M. Ülgen, “The influence of olanzapine on immune cells in patients with schizophrenia,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 27, no. 3, pp. 483–485, 2003. View at Publisher · View at Google Scholar · View at PubMed
  42. A. Sluzewska, J. K. Rybakowski, M. Laciak, A. Mackiewicz, M. Sobieska, and K. Wiktorowicz, “Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine,” Annals of the New York Academy of Sciences, vol. 762, pp. 474–476, 1995. View at Google Scholar
  43. Y. Barber, P. Toren, A. Achiron et al., “T cell subsets in obsessive-compulsive disorder,” Neuropsychobiology, vol. 34, no. 2, pp. 63–66, 1996. View at Google Scholar
  44. L. Lykouras, I. M. Zervas, R. Gournellis, M. Malliori, and A. Rabavilas, “Olanzapine and obsessive-compulsive symptoms,” European Neuropsychopharmacology, vol. 10, no. 5, pp. 385–387, 2000. View at Publisher · View at Google Scholar
  45. M. Maes, “Evidence for an immune response in major depression: a review and hypothesis,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 19, no. 1, pp. 11–38, 1995. View at Publisher · View at Google Scholar
  46. J. M. Petitto, M. J. Repetto, and D. A. Hartemink, “Brain-immune interactions in neuropsychiatry: highlights of the basic science and relevance to pathogenic factors and epiphenomena,” CNS Spectrums, vol. 6, no. 5, pp. 383–391, 2001. View at Google Scholar
  47. T. K. Murphy, J. M. Petitto, K. K. Voeller, and W. K. Goodman, “Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function?,” Seminars in Clinical Neuropsychiatry, vol. 6, no. 4, pp. 266–276, 2001. View at Publisher · View at Google Scholar
  48. T. K. Murphy, M. W. Sajid, and W. K. Goodman, “Immunology of obsessive-compulsive disorder,” Psychiatric Clinics of North America, vol. 29, no. 2, pp. 445–469, 2006. View at Publisher · View at Google Scholar